 The first TCA reported for the treatment of depression was imipramine, a dibenzazepine analogue of chlorpromazine code-named G22355.It was not originally targeted for the treatment of depression.The drug's tendency to induce manic effects was "later described as 'in some patients, quite disastrous'".